Ocular Therapeutix™ to Host Investor Day on June 17, 2026
Ocular Therapeutix will host an Investor Day on June 17, 2026, in New York City, featuring presentations from senior leadership and roundtable discussions with prominent retinal disease experts. The event will highlight the NDA submission plan for AXPAXLI in wet AMD, updates on the SOL-R and SOL-X trials, and the registrational program for diabetic retinopathy.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.